Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA 2023-12-27 20:50
First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection 2023-10-30 14:51
Boan Biotech's BA1202 Approved for Clinical Trial 2023-05-16 22:02
Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech's Dulaglutide Injection BA5101 in China 2023-05-15 21:58
First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102 2023-05-04 14:40
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil 2023-04-11 20:19
Boan Biotech Announces 2022 Financial Results 2023-03-27 23:15
1